Company news: Physicians Interactive, WorldOne, Bristol-Myers Squibb and Inhibitex

Share this article:

Physicians Interactive (PI) and WorldOne formed an exclusive strategic alliance to merge their US-based healthcare marketing research panels, firms said. The panel includes 300,000+ AMA-verified physicians amid a network of online and mobile HCPs spanning about a million physicians, nurses and allied health professionals in all major specialties, PI and WorldOne said. The alliance will enable HCPs to share insights with life science firms, market research organizations, academic centers and associations.

Bristol-Myers Squibb said it is buying hepatitis C drug developer Inhibitex for about $2.5 billion. The deal comes a few months before the patent is set to expire on BMS's biggest-selling drug, antiplatelet agent Plavix, and gives BMS access to Inhibitex's potential HCV drug INX-189. In November Gilead Sciences struck a $10.8 billion deal to buy experimental hepatitis C drug maker Pharmasset.

Share this article:

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.